Intercept Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Intercept Pharmaceuticals's balance sheet done over the years? Its assets were worth $553,711,000 last year, which is more than in the previous period. 83% of Intercept Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $460,634,000, which means an decrease by -35% compared compared to last year.
Debt to Assets
| 2013 | 150318580 | 67.91M | 45.18% |
|---|---|---|---|
| 2014 | 254149000 | 23.25M | 9.15% |
| 2015 | 655758000 | 53.60M | 8.18% |
| 2016 | 739253000 | 424.32M | 57.4% |
| 2017 | 484347000 | 467.96M | 96.62% |
| 2018 | 509167000 | 490.03M | 96.24% |
| 2019 | 754886000 | 703.33M | 93.17% |
| 2020 | 580489000 | 747.34M | 128.74% |
| 2021 | 527023000 | 710.98M | 134.91% |
| 2022 | 553711000 | 460.63M | 83.19% |
ICPT Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 50.51M | 84.70M | 58.15M | 70.05M | 436.16M | 414.91M | 689.38M | 628.05M | 239.72M | 13.36M |
Short term investments | 435.04M | 334.98M | 411.51M | 582.56M | 392.91M | 344.90M | 645.71M | 595.31M | 219.70M | 131.54M |
Net receivables | 26.86M | 47.61M | 41.54M | 38.04M | 25.69M | 18.57M | 12.33M | 3.69M | 2.55M | 1.37M |
Inventory | 6.46M | 8.61M | -68.57M | 8.46M | 7.10M | 1 | 2.27M | -3.64M | 3.54M | 1.27M |
Other current assets | 22.35M | 25.28M | 27.02M | 25.92M | 20.57M | 14.81M | 9.35M | 13.59M | 17 | -444 |
Total current assets | 540.12M | 502.29M | 477.17M | 721.31M | 482.42M | 448.30M | 707.86M | 641.69M | 245.82M | 147.56M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 987K | 9.49M | 18.65M | 18.44M | 10.41M | 16.18M | 11.29M | 10.04M | 5.85M | 1.67M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 12.59M | 15.23M | 84.66M | 15.12M | 16.33M | 19.85M | 20.09M | 4.01M | 2.46M | 1.08M |
Total non-current assets | 13.58M | 24.73M | 103.31M | 33.57M | 26.74M | 36.04M | 31.38M | 14.06M | 8.32M | 2.75M |
Total assets | 553.71M | 527.02M | 580.48M | 754.88M | 509.16M | 484.34M | 739.25M | 655.75M | 254.14M | 150.31M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 136.69M | 138.29M | 130.53M | 1.62M | 1.78M | 5.69M | 1.78M | 1.78M | 1.62M |
Short term debt | 109.56M | 3.04M | 7.24M | 6.45M | 82.49M | 0 | 0 | 0 | 10.33M | 4.06M |
Total current liabilities | 230.07M | 166.81M | 179.07M | 162.00M | 114.20M | 104.03M | 78.51M | 47.37M | 15.24M | 8.88M |
| Non-current liabilities: | ||||||||||
Long term debt | 223.10M | 544.16M | 568.26M | 532.07M | 371.25M | 355.67M | 341.35M | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 7.45M | 0 | 0 | 9.24M | 3.77M | 5.57M | -5.69M | -1.78M | -9.79M | 50.11M |
Total non-current liabilities | 230.55M | 544.16M | 568.26M | 541.32M | 375.83M | 363.92M | 345.80M | 6.23M | 8.01M | 59.03M |
Total liabilities | 460.63M | 710.98M | 747.34M | 703.33M | 490.03M | 467.96M | 424.32M | 53.60M | 23.25M | 67.91M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |